Rebus Biosystems Inc: Rebus Bio Continues Expansion of Industry-leading Spatial Omics Platform with Breakthrough High-Plex Technology
EEL assay overcomes well-known limitations in spatial biology Rebus Biosystems Inc, ("Rebus Bio", "Rebus"), an Illumina Ventures-backed life science technology company creating revolutionary tools
Paul Sargeant Kostenloser Wertpapierhandel Sten Linnarsson Simone Codeluppi Sweden Karolinska Institute Rebus Biosystems Inc
Source: finanznachrichten.de